Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Interim Management Statement

10 May 2010 07:00

RNS Number : 5791L
Tarsus Group PLC
10 May 2010
 



 

 

 

TARSUS GROUP plc

 

Interim Management Statement

 

Tarsus Group Plc ("Tarsus" or "the Group"), the international business-to-business media group, is today publishing its Interim Management Statement relating to the period from the publication of its Preliminary Results on 8 March 2010 to 9 May 2010.

 

Trading Performance

 

Trading for the period has been in line with the Board's expectations. A summary of major developments includes:

 

§ US - continued recovery & momentum

 

The Medical division continues to gain momentum. The April Orlando event produced revenues well ahead of last year, driven by very strong growth from its education programmes. Exhibition and conference revenues also grew for the first time in 18 months.

 

§ France - management action retains margins within expectations

 

A number of small exhibitions have taken place in France since 8 March. As expected, the declining revenue trends experienced in the second half of 2009 have continued into the first half of 2010. Strong cost management has resulted in margins remaining within our expectations.

 

§ Emerging Markets

 

No material events have taken place since 8 March.

 

Financial Position

 

There have been no significant changes to the financial position of the Group since the publication of the Preliminary Results on 8 March 2010.

 

Outlook

 

At our preliminary results at the start of March we announced the launch of "Project 50/13" to accelerate our scale in Emerging Markets. Our business infrastructure in the region is now established and Tarsus has a much improved platform within Asia and the Middle East from which to continue to drive strong growth.

 

As in previous years, the Group's revenues remain heavily second-half weighted and, overall, forward bookings remain at a similar level to 2009.

 

The French portfolio is weighted towards the 4th quarter of the year and we are now seeing signs of stabilisation in that market, with forward bookings for 4th quarter events at similar levels to last year. Given the current economic outlook for Europe, we continue to remain cautious.

 

US sales are strong and ahead of 2009, driven mainly by our Off-Price (discount clothing) and Medical divisions. Labelexpo America's sales are marginally behind the previous edition, owing to smaller exhibitors booking later in the cycle.

 

In the Emerging Markets division, the Group's largest event this year is MEBA (business aviation) which takes place in Dubai for which forward bookings are well ahead of the previous cycle.

 

Our view of trading for 2010 is unchanged with long term exhibition trends intact. The recovery in the US economy is benefiting our business in that market and we are seeing good growth prospects and opportunities in Emerging Markets. Our strong brands, diversified portfolio of market leading events and increased focus on Emerging Markets leave Tarsus well positioned for the future.

 

Tarsus Group plc:

 

Douglas Emslie, Group Managing Director 020 8846 2700

Ashley Milton, Group Finance Director 020 8846 2700

 

Media:

 

Madano Partnership

Matthew Moth 020 7593 4000

 

Investors/Analysts:

 

IRfocus

Neville Harris 020 7593 4015

 

Scott Harris

Stephen Scott, Jeremy Wiseman 020 7653 0030

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKKODKABKDOPK
Date   Source Headline
17th Mar 20114:31 pmRNSHolding(s) in Company
17th Mar 20114:28 pmRNSAcquisition
10th Mar 201112:00 pmRNSDirector/PDMR Shareholding
7th Mar 20117:00 amRNSFinal Results
21st Jan 201110:42 amRNSAdditional Listing
18th Jan 20114:36 pmRNSHolding(s) in Company
18th Jan 20114:36 pmRNSHolding(s) in Company
6th Jan 20117:00 amRNSTrading Statement
5th Jan 20114:29 pmRNSHolding(s) in Company
5th Jan 20114:27 pmRNSHolding(s) in Company
4th Jan 20117:00 amRNSTotal Voting Rights
20th Dec 20103:02 pmRNSScrip Dividend Circular
30th Nov 20102:37 pmRNSTotal Voting Rights
16th Nov 20107:00 amRNSInterim Management Statement
9th Nov 20104:58 pmRNSBlocklisting Interim Review
17th Sep 20104:55 pmRNSChange of Registered Office
31st Aug 20109:55 amRNSTotal Voting Rights
25th Aug 20106:14 pmRNSHolding(s) in Company
25th Aug 20106:12 pmRNSHolding(s) in Company
25th Aug 20106:11 pmRNSHolding(s) in Company
25th Aug 20106:09 pmRNSHolding(s) in Company
25th Aug 20106:07 pmRNSHolding(s) in Company
23rd Aug 20107:00 amRNSCompletion of Acquisition and Total Voting Rights
20th Aug 20104:14 pmRNSDirector/PDMR Shareholding
19th Aug 20101:50 pmRNSResult of Meeting
18th Aug 201010:55 amRNSInterim Financial Statements 2010
17th Aug 201010:41 amRNSDirector/PDMR Shareholding
30th Jul 201010:53 amRNSTotal Voting Rights
28th Jul 20107:01 amRNSPosting of Circular
28th Jul 20107:00 amRNSInterim Results
26th Jul 20103:22 pmRNSApplication for Admission
5th Jul 20103:55 pmRNSApplication for admission
30th Jun 20107:00 amRNSPre-close Trading Statement
17th Jun 20105:10 pmRNSDirector/PDMR Shareholding
16th Jun 20102:48 pmRNSResult of AGM
7th Jun 20102:31 pmRNSCirc re. Scrip Dividend
14th May 201012:21 pmRNSAmendment to Notice of Annual General Meeting
10th May 20104:58 pmRNSAnnual Information Update
10th May 20107:00 amRNSInterim Management Statement
7th May 201011:14 amRNSBlocklisting Six Monthly Return
30th Apr 201010:05 amRNSTotal Voting Rights
13th Apr 20105:31 pmRNSDirector/PDMR Shareholding
12th Apr 20101:36 pmRNSAnnual Reports and Accounts
9th Apr 20104:44 pmRNSHolding(s) in Company
1st Apr 20104:33 pmRNSNotification of Interests in Shares
31st Mar 20109:48 amRNSTotal Voting Rights
8th Mar 20107:00 amRNSAcquisition
8th Mar 20107:00 amRNSFinal Results
5th Mar 20107:00 amRNSDirectorate Change
22nd Feb 20107:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.